$78.38
-0.52-0.66%
At Close: -
$79.38
11.27%
After Hours: 7:57 PM EDT
15 minutes delayed
Comments
Loading...
Latest news for AstraZeneca (NASDAQ:AZN) Stock
AstraZeneca Stock (NASDAQ: AZN)
Categories: All
Friday, September 20, 2024
Thursday, September 19, 2024
Wednesday, September 18, 2024
Monday, September 16, 2024
Friday, September 13, 2024
Wednesday, September 11, 2024
Tuesday, September 10, 2024
Monday, September 09, 2024
- Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
- AstraZeneca PLC shares are trading lower afte...
- AstraZeneca Says Datopotamab Deruxtecan Showe...
- Datopotamab Deruxtecan Shows Median Overall S...
- AstraZeneca And Daiichi Sankyo's Datopotamab ...
- Innate Pharma And AstraZeneca Reveal Monalizu...
Thursday, September 05, 2024
Wednesday, September 04, 2024
Tuesday, September 03, 2024
Friday, August 23, 2024
Tuesday, August 20, 2024
Monday, August 19, 2024
Friday, August 16, 2024
Thursday, August 15, 2024
Wednesday, August 14, 2024
Tuesday, August 13, 2024
- Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
- New European Regulations Could Hinder Rare Disease Treatments, Pharma Industry Raises Concerns Over Stricter Clinical Trial Rules
- Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
- AstraZeneca Announced Enhertu Approved In Chi...